Noncoding RNAs as Biomarkers for Acute Coronary Syndrome

Abstract EN

Acute coronary syndrome (ACS), consisting of acute myocardial infarction and unstable angina, is the most dangerous and fatal form of coronary heart disease.

Acute coronary syndrome has sudden onset and rapid development, which may lead to malignant life-threatening conditions at any time.

Therefore, early detection and diagnosis are critical for patients with ACS.

Recent studies have found that noncoding RNA is of great significance in the diagnosis and treatment of cardiovascular diseases.

In this review, we summarized recent data on circulating noncoding RNAs (including microRNA, long noncoding RNA, and circular RNA) as diagnostic and prognostic markers in ACS including acute myocardial infarction and unstable angina.

Specifically, microRNAs (miRNAs) as diagnostic markers are divided into three types: miRNAs of increased expression in ACS, miRNAs of decreased expression in ACS, and miRNAs of contradictory expression in ACS.

Moreover, we described these miRNAs of increased expression in ACS based on miRNAs family.

This review may result in a great guidance of noncoding RNAs as biomarkers for ACS in clinical practice.